Science and research
Capacity for basic and clinical science; funding for clinical research; trained nurses/staff for clinical research.
Capacity to train nurses for patient care and patient education and to provide qualified nursing support.
Capacity for clinical research; need for research laboratories; need for research equipment.
Capacity to investigate local incidence and characteristics of breast cancer; IT capacity to support national registries and research.
Capacity for national public education and awareness campaigns on breast cancer and screening.
Study of local etiology
Evidence identifying differences between local patients and those in the UK/USA; younger women; more aggressive tumor morphology.
Evidence to promote personalized therapy; includes using genetic targets to tailor treatment.
Research in local populations and other evidence to inform local guidelines and policies; national treatment guidelines and coordination.
Connecting to evidence internationally; keeping up to date; global research programs, networking and education opportunities.
Communicating evidence across stakeholders; improved communications between/within institutions and across institutions within areas or the country.
Barriers due to out-of-pocket expenses paid for by the patient.
Disparities in access
Barriers for underserved and rural populations.
High cost to payers
Barriers to reimbursing high-cost treatments.
Barriers to accessing earlier detection.
Barriers to accessing therapies that are not yet proven to be cost effective.
Strategies to empower patients/patient groups and inform consumers.
Support increased focus on survivors; long-term side-effects and quality of life.
Quality of life
Support increased focus in research and practice on quality of life.
Support for the management of metastatic disease.
Support for leadership and staffing of advocacy groups; communication between advocacy groups.